|
ZRANB1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.61870516990348E-13 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
1.30439999912468E-08 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
7.105427357601E-15 |
| Stage1-vs-Stage2 |
3.450000E-01 |
| Stage1-vs-Stage3 |
7.320100E-02 |
| Stage1-vs-Stage4 |
3.652100E-02 |
| Stage2-vs-Stage3 |
4.147500E-02 |
| Stage2-vs-Stage4 |
1.403610E-02 |
| Stage3-vs-Stage4 |
5.079200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.66133814775094E-14 |
| Normal-vs-AfricanAmerican |
3.80429999999876E-05 |
| Normal-vs-Asian |
1.89920301707502E-11 |
| Caucasian-vs-AfricanAmerican |
6.956300E-02 |
| Caucasian-vs-Asian |
6.035000E-01 |
| AfricanAmerican-vs-Asian |
1.867760E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.89859239441148E-12 |
| Normal-vs-Female |
1.62458935193399E-12 |
| Male-vs-Female |
8.198200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.71382916139373E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.70963243562028E-12 |
| Normal-vs-Age(81-100Yrs) |
9.79930000000184E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.892000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.681600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.681000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.528600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.704200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.554200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.181000E-04 |
| Classical-VS-Follicular |
3.686400E-01 |
| Classical-VS-Other |
5.232000E-01 |
| Classical-VS-Normal |
2.21479501405497E-11 |
| Tall-VS-Follicular |
3.060300E-02 |
| Tall-VS-Other |
3.956200E-01 |
| Tall-VS-Normal |
1.63935531816151E-12 |
| Follicular-VS-Other |
7.750000E-01 |
| Follicular-VS-Normal |
2.48256970536431E-12 |
| Other-VS-Normal |
7.411500E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
5.21804821573824E-15 |
| N0-vs-N1 |
4.177800E-02 |
|
|
